1281 - 1290 of 8826 Results
Title
Year
-
OPENTitle: A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic InflammationJournal Name: DrugsPublisher: Springer Science and Business Media LLCVol: 83Issue #: 5Start Page: 389End Page: 402Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s40265-023-01838-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40265-023-01838-z.pdfCitation Count: 32
-
OPENTitle: Systematic Review on Parkinson’s Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson’s SymptomsJournal Name: International Journal of Environmental Research and Public HealthPublisher: MDPI AGVol: 19Issue #: 1Start Page: 364End Page: 364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijerph19010364Best OA location URL: https://www.mdpi.com/1660-4601/19/1/364/pdf?version=1641285359Citation Count: 67
-
OPENTitle: Clearing the Smoke: What Protects Smokers from Parkinson's Disease?Journal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 2Start Page: 267End Page: 272Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29707Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29707Citation Count: 21
-
OPENTitle: Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as BiomarkersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 669End Page: 683Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28941Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28941Citation Count: 78
-
OPENTitle: Positron Emission Tomography Imaging in Clinical Trials for Parkinson's Disease: Applications of Metabolic Brain Network ApproachJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 8Start Page: 1511End Page: 1527Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.30231Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30231Citation Count: 0
-
OPENTitle: Constructing and exploring neuroimaging projects: a survey from clinical practice to scientific researchJournal Name: Insights into ImagingPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 272End Page: 272Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13244-024-01848-9Best OA location URL: https://insightsimaging.springeropen.com/counter/pdf/10.1186/s13244-024-01848-9Citation Count: 1
-
OPENTitle: Transcriptional landscape of human microglia implicates age, sex, and APOE‐related immunometabolic pathway perturbationsJournal Name: Aging CellPublisher: WileyVol: 21Issue #: 5Start Page: e13606End Page: e13606Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.13606Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/acel.13606Citation Count: 52
-
OPENTitle: Radioligands Targeting the Purinergic P2X ReceptorsJournal Name: CellsPublisher: MDPI AGVol: 14Issue #: 13Start Page: 984End Page: 984Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells14130984Best OA location URL: https://www.mdpi.com/2073-4409/14/13/984/pdf?version=1751010309Citation Count: 0
- Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease2022RESTRICTEDTitle: Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s diseaseJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 22Issue #: 6Start Page: 489End Page: 498Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2022.2091436Citation Count: 15
-
OPENTitle: Therapeutic potential of autophagy-enhancing agents in Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 11End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-017-0154-3Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-017-0154-3Citation Count: 266